Search results for "chronic"

showing 10 items of 3309 documents

New horizons in early stage COPD--improving knowledge, detection and treatment.

2011

SummaryEarly stage COPD carries a significant healthcare burden that is currently underrecognised, underdiagnosed and undertreated. Furthermore, patients at this stage can rapidly decline to advanced disease, especially if they continue to smoke. The natural history of the disease in early stages remains largely unknown, and emerging evidence indicates that we are able to reduce lung function decline and exacerbations, and improve quality of life, in early stage COPD, mainly through smoking cessation. But new evidence from randomised clinical trials also suggests an impact of pharmacotherapy on clinical outcomes in early disease. Guidelines need to be updated to reflect this greater underst…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyHealth Knowledge Attitudes Practicemedicine.medical_treatmentDiseasePulmonary Disease Chronic ObstructiveQuality of life (healthcare)PharmacotherapyHealth careDiagnosismedicineCOPDHumansIntensive care medicineCOPDbusiness.industryCase-findingEarly diseasemedicine.diseasePrognosisBronchodilator AgentsClinical trialNatural historyTreatmentEarly DiagnosisSpirometryPractice Guidelines as TopicPhysical therapyQuality of LifeSmoking cessationFemaleSmoking CessationbusinessRespiratory medicine
researchProduct

Association between reduced bronchodilatory effect of deep inspiration and loss of alveolar attachments.

2005

Abstract Background We have previously shown that the bronchodilatory effect of deep inspiration is attenuated in individuals with COPD. This study was designed to investigate whether the impairment in this effect is associated with loss of alveolar attachments. Methods We measured deep inspiration (DI)-induced bronchodilation in 15 individuals with and without COPD (67 ± 2.2 yrs of age, mean ± SEM) undergoing lobar resection for peripheral pulmonary nodule. Prior to surgery, we measured TLCO and determined the bronchodilatory effect of deep inspiration after constricting the airways with methacholine. The number of destroyed alveolar attachments, as well as airway wall area and airway smoo…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPathologyStatistics as TopicBronchial provocation testsCOPD lung inflationBronchi030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato RespiratorioBronchial Provocation Tests03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicinemedicineHumansLung volumesMethacholine ChlorideAgedlcsh:RC705-779COPDbusiness.industryResearchAirway smooth musclelcsh:Diseases of the respiratory systemrespiratory systemmedicine.diseaserespiratory tract diseasesPulmonary Alveoli030228 respiratory systemMethacholine chlorideInhalationAirway wallCardiologyMethacholineFemalebusinessmedicine.drugRespiratory research
researchProduct

Direct effect of cigarette smoke on human pulmonary artery tension.

2010

The effect of chronic cigarette smoke on pulmonary artery (PA) tension has been studied extensively; nevertheless, the direct effect of cigarette smoke is poorly understood. We investigated the direct effect of cigarette smoke extract (CSE) on PA tension in non-smokers, smokers, and COPD patients in vitro. PA samples from 35 patients who underwent lung resection were examined by measuring isometric tension in response to increasing serotonin concentrations. CSE dose dependently inhibited the response to serotonin in smokers and COPD patients, and to a lesser extent in non-smokers. CSE-induced relaxation was similarly inhibited by the nonspecific nitric oxide synthase (NOS) inhibitor l-NOARG…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtySerotoninContraction (grammar)In Vitro TechniquesPulmonary ArteryNitroarginineMuscle Smooth VascularFEV1/FVC ratioPulmonary Disease Chronic ObstructiveEnosInternal medicinemedicine.arterySmokeparasitic diseasesTobaccomedicineHumansPharmacology (medical)5-HT receptorCOPDbiologyDose-Response Relationship Drugbusiness.industryLysineBiochemistry (medical)biology.organism_classificationmedicine.diseaserespiratory tract diseasesNitric oxide synthaseEndocrinologyAnesthesiaPulmonary arterybehavior and behavior mechanismsbiology.proteinFemaleSerotoninNitric Oxide SynthasebusinessMuscle ContractionPulmonary pharmacologytherapeutics
researchProduct

Effects Of Whole Body Vibration In Patients With Chronic Obstructive Pulmonary Disease - A Randomized Controlled Trial

2012

Summary Introduction To date endurance and strength training are established and evidence-based exercise methods in patients with chronic obstructive pulmonary disease (COPD). There is an unmet need for further research in new and complementary exercise modalities. Additional whole body vibration training during pulmonary rehabilitation may be such a new approach that has not yet been investigated in patients with COPD. Methods Eighty-two patients (65 ± 9 yrs, FEV 1 pred. 38 ± 11%, female 51%) with COPD in GOLD stage III to IV assessed for a 3-week inpatient multidisciplinary rehabilitation program were on top randomly assigned to one of two intervention groups: (1) 3 × 3 min of bilateral d…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyTime FactorsStrength trainingmedicine.medical_treatmentSquatWalkingVibrationlaw.inventionPulmonary Disease Chronic ObstructiveRandomized controlled trialQuality of lifelawTrainingHumansMedicineWhole body vibrationIn patientPulmonary rehabilitationProspective StudiesProspective cohort studyExercisePhysical Therapy ModalitiesAgedCOPDExercise Tolerancebusiness.industryChronic obstructive pulmonary diseaseMinimal clinically important differencemedicine.diseaseRespiratory MusclesExercise TherapyRespiratory Function TestsPulmonary rehabilitationTreatment OutcomePhysical therapyFemalebusinessWhole body vibrationA107. ASSESSMENT, EXERCISE TRAINING AND OUTCOMES
researchProduct

Tiotropium + olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema

2017

Introduction: Chronic bronchitis and emphysema are two COPD phenotypes that can affect pharmacologic treatment decisions. Aims: Tiotropium (T) + olodaterol (O) was established for COPD treatment in two large Phase III trials. This post hoc analysis assessed the effect of T+O on lung function, symptoms and health-related quality of life (QoL) in patients (pts) with investigator-defined bronchitis and/or emphysema. Methods: TONADO ® 1+2 were replicate, randomised, double-blind, parallel-group trials. Pts with GOLD 2–4 COPD were randomised to once-daily T+O 2.5/5 or 5/5 µg, T 2.5 or 5 µg, or O 5 µg via Respimat ® inhaler. 1 End points included forced expiratory volume in 1 second (FEV 1 ) area…

Pulmonary and Respiratory MedicineModerate to severeChronic bronchitismedicine.medical_specialtyRespimatPhysiologyGastroenterology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineIn patientRespiratory systemCOPDbusiness.industryInhalerOlodaterolArea under the curveTiotropium-olodaterolmedicine.diseaserespiratory tract diseasesSurgerychemistry030220 oncology & carcinogenesisBronchitisbusiness030217 neurology & neurosurgeryPneumologie
researchProduct

Synchronous Two Distinct Neuroendocrine Lung Cancer Lesions

2015

Synchroniczne nowotwory płuc są rzadką chorobą, a prezentowany przypadek to pierwszy opublikowany opis jednoczesnego wystąpienia dwóch pierwotnych neuroendokrynnych raków płuca zlokalizowanych w jednym płacie. Przedstawiono przypadek 55-letniej pacjentki z dwoma pierwotnymi, odrębnymi neuroendokrynnymi rakami płata górnego płuca prawego. Pacjentka została przyjęta na oddział chirurgii klatki piersiowej w celu diagnostyki dwóch cieni okrągłych płuca prawego (o średnicy 11 i 19 mm) uwidocznionych na zdjęciu RTG klatki piersiowej wykonanym trzy miesiące wcześniej. Przy przyjęciu pacjentka nie prezentowała żadnych objawów związanych ze zmianami w płucu. Dalsze badania obrazowe wykazały zmiennoś…

Pulmonary and Respiratory MedicinePathologymedicine.medical_specialtyLung NeoplasmsLung biopsySmall-cell carcinomasynchronous primary lung cancerNeoplasms Multiple PrimarymedicineHumansCarcinoma Small CellLung cancerdrobnokomórkowy rak płucalarge cell neuroendocrine carcinomasmall cell carcinomaEtoposideCisplatinLungbusiness.industrywielkokomórkowy neuroendokrynny rak płucaNeoplasms Second PrimaryMiddle Agedmedicine.diseaseCarcinoma Neuroendocrinemedicine.anatomical_structureCardiothoracic surgeryFemaleProphylactic cranial irradiationTomography X-Ray Computedbusinesssynchroniczny rak płucamedicine.drugAdvances in Respiratory Medicine
researchProduct

Contribution of bronchial biopsies in the evaluation of pathogenesis and progression of COPD.

2016

This review summarizes and discusses the lung pathology of COPD patients emphasising on inflammatory cell phenotypes and mechanisms which prevail in different clinical conditions. In bronchial biopsies a series of events takes place during the progression of the disease from mild to severe. T-lymphocytes, particularly CD8+ cells and macrophages are the prevalent inflammatory cells in the lungs of healthy smokers and patients with mild/moderate COPD. This T-cell activation seems to be sustained by CD4+, CD8+ cells and macrophages expressing transcription factors and Tc1 cytokines such as NF-kB, STAT4 and IFNγ. In contrast, severe disease is characterized by lymphocytes producing greater amo…

Pulmonary and Respiratory MedicinePathologymedicine.medical_specialtyinflammatory cellsBiopsylcsh:MedicineContext (language use)BronchiPathogenesischemistry.chemical_compoundPulmonary Disease Chronic ObstructivemedicineCOPDHumansSTAT4COPDbiologybusiness.industryNitrotyrosineCD44lcsh:Rmedicine.diseasebronchial biopsiesNeutrophiliarespiratory tract diseaseschemistryIntegrin alpha MImmunologybiology.proteinmedicine.symptomCardiology and Cardiovascular MedicinebusinessMonaldi archives for chest disease = Archivio Monaldi per le malattie del torace
researchProduct

Clinical implications of airway hyper-responsiveness in COPD

2006

COPD represents one of the leading causes of mortality in the general population. This study aimed at evaluating the relationship between airway hyperresponsiveness (AHR) and COPD and its relevance for clinical practice. We performed a MEDLINE search that yielded a total of 1919 articles. Eligible studies were defined as articles that addressed specific aspects of AHR in COPD, such as prevalence, pathogenesis, or prognosis. AHR appears to be present in at least one out of two individuals with COPD. The occurrence of AHR in COPD is influenced by multiple mechanisms, among which impairment of factors that oppose airway narrowing plays an important role. The main determinants of AHR are reduct…

Pulmonary and Respiratory MedicinePathologymedicine.medical_specialtymedicine.medical_treatmentMEDLINEPopulationReviewsSettore MED/10 - Malattie Dell'Apparato RespiratorioBioinformaticsBronchial Provocation TestsPathogenesisDiagnosis DifferentialMedical Subject HeadingsPulmonary Disease Chronic ObstructivePredictive Value of TestsmedicineRespiratory HypersensitivityCOPDHumansairway smooth muscle aging bronchial obstructioneducationLungAsthmaCOPDeducation.field_of_studyLungbusiness.industryHealth Policyairway hyperresponsivenessSmokingPublic Health Environmental and Occupational HealthGeneral Medicinerespiratory systemmedicine.diseasePrognosisAsthmarespiratory tract diseasesbronchial hyperreactivitymedicine.anatomical_structurePredictive value of testsSmoking cessationbusinessAirwayInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Physician specialty as a source of heterogeneity in the care of patients with COPD.

2011

Pulmonary and Respiratory MedicinePatient Care TeamCOPDmedicine.medical_specialtybusiness.industryInterprofessional RelationsCritical Care and Intensive Care Medicinemedicine.diseasePhysician specialtyPulmonary Disease Chronic ObstructiveItalyFamily medicinePulmonary MedicineMedicineHumansMedicineCardiology and Cardiovascular MedicinebusinessPhysician's RoleChest
researchProduct

An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.

2016

Asthma in the elderly (>65 yr old) is common and associated with higher morbidity and mortality than asthma in younger patients. The poor outcomes in this group are due, in part, to underdiagnosis and undertreatment. There are a variety of factors related to aging itself that affect the presentation of asthma in the elderly and influence diagnosis and management. Structural changes in the aging lung superimposed on structural changes due to asthma itself can worsen the disease and physiologic function. Changes in the aging immune system influence the cellular composition and function in asthmatic airways. These processes and differences from younger individuals with asthma are not well u…

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyAgingImmunosenescenceaging; immunosenescence; lung function; phenotype; reactive airways diseaseDiseaseComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioAffect (psychology)Diagnosis Differential03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineimmune system diseasesreactive airways diseasemedicineHumans030212 general & internal medicineDisease management (health)LungSocieties MedicalAsthmaAgedAmerican Thoracic Society DocumentsLungbusiness.industryDisease Managementlung functionImmunosenescencemedicine.diseaseComorbidityAsthmaUnited Statesrespiratory tract diseasesmedicine.anatomical_structurePhenotype030228 respiratory systemPhysical therapyAge of onsetbusinessBiomarkersAnnals of the American Thoracic Society
researchProduct